Lumos Diagnostics Holdings (ASX:LDX) Total Inventories : A$2.13 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings Total Inventories?

Lumos Diagnostics Holdings's total inventories for the quarter that ended in Dec. 2024 was A$2.13 Mil. Lumos Diagnostics Holdings's average total inventories from the quarter that ended in Jun. 2024 to the quarter that ended in Dec. 2024 was A$1.65 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Lumos Diagnostics Holdings's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was A$-0.02.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Lumos Diagnostics Holdings's Days Inventory for the six months ended in Dec. 2024 was 92.42.

Inventory Turnover measures how fast the company turns over its inventory within a year. Lumos Diagnostics Holdings's Inventory Turnover for the quarter that ended in Dec. 2024 was 1.97.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Lumos Diagnostics Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.17.

Lumos Diagnostics Holdings Total Inventories Historical Data

The historical data trend for Lumos Diagnostics Holdings's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings Total Inventories Chart

Lumos Diagnostics Holdings Annual Data

Trend

Jun22

Jun23

Jun24

Total Inventories

3.59

1.58

1.18

Lumos Diagnostics Holdings Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Inventories	Get a 7-Day Free Trial			2.39	1.58	2.00	1.18	2.13

Lumos Diagnostics Holdings Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Lumos Diagnostics Holdings (ASX:LDX) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Lumos Diagnostics Holdings's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is

	Net-Net Working Capital Per Share (Q: Dec. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(8.735	+	0.75 * 3.647	+	0.5 * 2.125	-	26.376
-	0	-	0)	/	748.523
=	-0.02

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Lumos Diagnostics Holdings's Days Inventory for the six months ended in Dec. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2024 )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
	=	1.653	/	3.264	*	365 / 2
	=	92.42

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Lumos Diagnostics Holdings's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2024 )	/	Average Total Inventories (Q: Dec. 2024 )
	=	3.264	/	1.653
	=	1.97

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Lumos Diagnostics Holdings's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	1.653	/	9.957
	=	0.17

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Lumos Diagnostics Holdings Total Inventories Related Terms

Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Lumos Diagnostics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lumos Diagnostics Holdings Ltd (ASX:LDX) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

LDXHF:USA

Address

2724 Loker Avenue West, Carlsbad, CA, USA, 92010

Website

https://www.lumosdiagnostics.com

Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture, and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. The group is dedicated to providing contract research and development services, focusing on the innovation, development, manufacturing, and commercialization of point-of-care diagnostic solutions for both clinical and consumer applications. It generates maximum revenue from commercial services and solutions relating to POC diagnostic tests. The group has one operating segment, which is the provision of point-of-care diagnostics goods and services, and it operates across two geographical regions, the United States and Australia. and the majority of revenue is generated from the United States.

Lumos Diagnostics Holdings Headlines

No Headlines